TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.8200
+0.0400 (5.13%)
At close: Nov 6, 2026, 4:00 PM EST
0.8364
+0.0164 (2.00%)
After-hours: Nov 6, 2026, 6:48 PM EST

TELA Bio Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, TELA Bio stock has a consensus rating of "Strong Buy" and an average price target of $1.90. The average 1-year stock price forecast is 131.71% higher than the current stock price, while the lowest is $1.00 (+21.95%) and the highest is $2.50 (+204.88%).

Price Target: $1.90 (+131.71%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$1.00$1.90$2.00$2.50
Change+21.95%+131.71%+143.90%+204.88%
* Price targets were last updated on Sep 30, 2026.

Analyst Ratings

The average analyst rating for TELA Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingDec '25Mar '26May '26Aug '26Sep '26Oct '26
Strong Buy333344
Buy111110
Hold111111
Sell000000
Strong Sell000000
Total555565

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Lake Street
Lake Street
Buy
Reiterates
$2
BuyReiterates$2+143.90%Sep 30, 2026
Craig-Hallum
Craig-Hallum
Buy
Initiates
$2
BuyInitiates$2+143.90%Sep 25, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$2
BuyMaintains$2+143.90%Sep 1, 2026
Piper Sandler
Piper Sandler
Hold
Maintains
$1
HoldMaintains$1+21.95%Aug 11, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
79.50M
from 80.28M
Decreased by -0.96%
Revenue Next Year
86.33M
from 79.50M
Increased by 8.58%
EPS This Year
-0.70
from -0.83
EPS Next Year
-0.45
from -0.70
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
29.46M41.42M58.45M69.30M80.28M79.50M
Revenue Growth
61.77%40.58%41.13%18.56%15.84%-0.96%
Gross Profit
19.12M27.85M40.49M46.87M54.72M54.60M
Gross Margin
64.88%67.24%69.27%67.63%68.17%68.68%
Operating Income
-29.45M-39.01M-44.08M-41.70M-33.76M-32.99M
Net Income
-33.28M-44.30M-46.66M-37.84M-38.83M-40.11M
EPS
-----0.83-0.70
Free Cash Flow
------34.05M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High80.6M
Avg79.5M
Low77.6M

Revenue Growth

Revenue Growth202620272028
High
0.4%
Avg
-1.0%
Low
-3.3%

EPS Forecast

EPS202620272028
High-0.66
Avg-0.70
Low-0.76

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-